UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Lowers Holdings in Doximity, Inc. (NASDAQ:DOCS)

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lowered its holdings in shares of Doximity, Inc. (NASDAQ:DOCS) by 17.2% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,233,291 shares of the company’s stock after selling 255,612 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned approximately 0.66% of Doximity worth $53,734,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the business. MetLife Investment Management LLC grew its stake in Doximity by 0.6% during the third quarter. MetLife Investment Management LLC now owns 65,064 shares of the company’s stock valued at $2,835,000 after acquiring an additional 363 shares in the last quarter. FMR LLC boosted its holdings in shares of Doximity by 30.5% during the 3rd quarter. FMR LLC now owns 6,837,733 shares of the company’s stock valued at $297,920,000 after purchasing an additional 1,598,602 shares during the last quarter. West Tower Group LLC purchased a new position in shares of Doximity during the third quarter valued at about $174,000. Harvest Fund Management Co. Ltd increased its holdings in shares of Doximity by 197.1% in the third quarter. Harvest Fund Management Co. Ltd now owns 9,020 shares of the company’s stock worth $393,000 after purchasing an additional 5,984 shares during the last quarter. Finally, Penserra Capital Management LLC purchased a new stake in shares of Doximity in the third quarter worth about $2,384,000. Institutional investors own 87.19% of the company’s stock.

Doximity Price Performance

Shares of DOCS stock opened at $54.20 on Wednesday. The company has a market capitalization of $10.12 billion, a P/E ratio of 62.30, a P/E/G ratio of 4.28 and a beta of 1.40. The company’s 50-day simple moving average is $46.10 and its two-hundred day simple moving average is $36.39. Doximity, Inc. has a one year low of $22.96 and a one year high of $61.75.

Wall Street Analyst Weigh In

A number of research firms have issued reports on DOCS. Barclays lifted their price objective on Doximity from $52.00 to $75.00 and gave the stock an “overweight” rating in a research note on Monday, November 11th. Raymond James restated an “outperform” rating and issued a $65.00 price target (up previously from $37.00) on shares of Doximity in a research report on Friday, November 8th. Truist Financial increased their price objective on shares of Doximity from $35.00 to $49.00 and gave the company a “hold” rating in a research report on Thursday, November 14th. Wells Fargo & Company upgraded shares of Doximity from an “underweight” rating to an “equal weight” rating and boosted their target price for the stock from $19.00 to $41.00 in a report on Friday, November 8th. Finally, JPMorgan Chase & Co. increased their price target on shares of Doximity from $30.00 to $48.00 and gave the company a “neutral” rating in a report on Thursday, November 21st. Eleven analysts have rated the stock with a hold rating, six have issued a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, Doximity currently has a consensus rating of “Hold” and a consensus price target of $52.27.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.